Skip to main content
SpringerPlus
Figure 3 | SpringerPlus

Figure 3

From: Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC)

Figure 3

CYP17A1 and AKR1C3 expression in BPH-1 and PC3: increased CYP17A1 and decreased AKR1C3 mRNA in BPH-1 after treatment with 25 μM AA (A + B). In PC-3 no significant effects after AA treatment in CYP17A1 and AKR1C3 mRNA expression could be seen (C + D); (*= p < 0.05, **= p < 0.005 and ***= p < 0.0005).

Back to article page